Evaluation of the Effectiveness of Pharmacists in Implementing the SCRIPT Protocol

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Pregnancy
Interventions
BEHAVIORAL

pharmacist nicotine cessation counseling using SCRIPT protocol

"Participant will be shown a short DVD Commit to Quit: During and After Pregnancy. She will be given a Pregnant Woman's Guide to Quitting booklet.~Participant will be asked their nicotine use status and it will be confirmed with a CO meter test and cotinine urine test. Those not consenting to be part of the study will not receive the urinalysis.~Participant will be advised to quit smoking. The pharmacist will review the Guide with the participant. The participant will receive a phone call around the time of their quit/reduction date. The participant will meet again approximately one week after their quit/reduction date and receive a CO meter test and urine cotinine test.~At the end of the program pregnant women will answer a follow-up questionnaire. Those women participating in the research study will be given a cotinine urine test at approximately \> 36 weeks gestation or at delivery."

Trial Locations (1)

99207

Providence Holy Family Hospital Anticoagulation and Pharmacotherapy Clinic, Spokane

All Listed Sponsors
lead

Providence Medical Research Center

OTHER

NCT02433860 - Evaluation of the Effectiveness of Pharmacists in Implementing the SCRIPT Protocol | Biotech Hunter | Biotech Hunter